大動脈弁 大動脈弁狭窄症の超音波新規治療法：Lancet. 2023 Dec 16;402(10419):2317-2325.
Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study Emmanuel Mes...
弁膜症
大動脈弁 弁膜症 低リスクTAVIの5年予後：N Engl J Med. 2023 Nov 23;389(21): 1949-1960.
Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years Michael J Mack, et al. N Engl J Med. 2023 Nov ...
三尖弁 三尖弁のカテーテル治療：N Engl J Med. 2023 May 18;388 (20):1833-1842.
Transcatheter Repair for Patients with Tricuspid Regurgitation Paul Sorajja, et al. N Engl J Med. 2023 May 18;388 (20):1...
僧帽弁 僧帽弁手術でアブレーションを追加することで転機はどうなる？：J Am Coll Cardiol. 2019 May 21;73 (19):2427-2435.
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation Joseph J DeRose Jr, et al. J Am Coll...
僧帽弁 Ischemic MRへのMVPは周術期リスクを下げるが再発が多い：Medicine (Baltimore). 2018 Aug;97 (31):11546.
Repair or replacement for severe ischemic mitral regurgitation: A meta-analysis Xinxin Wang, et al. Medicine (Baltimore)...
弁膜症 AVPの転機に影響を与える因子は？：J Thorac Cardiovasc Surg. 2021 Apr 16;S0022-5223(21)00612-7.
Late results of aortic valve repair for isolated severe aortic regurgitation Saadallah Tamer, et al. J Thorac Cardiovasc...
僧帽弁 Severe Ischemic MRに対するMVPは術後再発しやすい：N Engl J Med. 2016 Jan 28;374 (4):344-53.
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation Daniel Goldstein, et al. N Engl J Med. 2...
弁膜症 エネルギー損失/心拍出量はAVR後左室駆出率改善に相関する：Interactive Cardiovascular and Thoracic Surgery(2021)1-9
Blood flow energy loss: a predictor for the recovery of left ventricular function after bioprosthetic aortic valve repla...
弁膜症 AVRでウシ弁とブタ弁の違いは？：J Card Surg. 2022 Dec;37 (12):4555-4561.
Outcomes of bovine versus porcine surgical aortic valve replacement Sarah Yousef, et al. J Card Surg. 2022 Dec;37 (12):4...
弁膜症 心臓手術時のARへの介入なしは長期生存率に有意な影響を与えない：J Thorac Cardiovasc Surg. 2022 Dec;164 (6):1784-1792.1.
Fate of moderate aortic regurgitation after cardiac surgery Austin Ward, et al. J Thorac Cardiovasc Surg. 2022 Dec;164 (...